InSilico Medicine Cayman TopCo (INSILICO, HKEx: 03696) reported a 0.53% increase in its issued share capital following the allotment of 3.05 million new ordinary shares between 2 July and 6 July 2026.

Key data

• Opening share count (30 Jun 2026): 575.84 million shares.

• New shares issued under Pre-IPO Equity Incentive Plans:  – 02 Jul: 0.76 million shares at HKD 6.3493 each (non-director option exercise).  – 03 Jul: 0.29 million shares at HKD 7.9331 each (non-director option exercise).  – 06 Jul: 0.40 million shares at HKD 9.9163 each (non-director option exercise).  – 06 Jul: 1.60 million shares at nil consideration (director share-award vesting).

• Closing share count (06 Jul 2026): 578.89 million shares.

No treasury shares were held, repurchased, or cancelled during the period, and the board confirmed full compliance with Hong Kong listing and regulatory requirements.